Pathozone 250 mg Intramammary Suspension for Cattle

Main information

  • Trade name:
  • Pathozone
  • Pharmaceutical form:
  • Intramammary suspension
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Pathozone
    Germany
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • cefoperazone
  • Therapeutic area:
  • Cattle

Other information

Status

  • Source:
  • HMA - Europe
  • Authorization number:
  • UK/V/0421/001
  • Authorization date:
  • 16-11-2012
  • EU code:
  • UK/V/0421/001
  • Last update:
  • 09-08-2016

Summary of Product characteristics: dosage,interactions,side effects

ISSUED:December2012

AN:01574/2011

Page1of4

SUMMARYOFPRODUCTCHARACTERISTICS

1. NAMEOFTHEVETERINARYMEDICINALPRODUCT

Pathozone250mgIntramammarySuspensionforCattle

2. QUALITATIVEANDQUANTITATIVECOMPOSITION

mg/10ml

Activesubstance: Cefoperazone 250

(asthesodiumsalt) 258.9

Excipients: all-rac- α-Tocopherol(E307) 4.6

Forafulllistofexcipients,seesection6.1.

3. PHARMACEUTICALFORM

IntramammarySuspension.

Whitetooff-whiteoilysuspension

4. CLINICALPARTICULARS

4.1Targetspecies

Cattle(lactatingdairycows).

4.2Indicationsforuse,specifyingthetargetspecies

Theproductisindicatedforthetreatmentofclinicalmastitisinlactatingcows.

Clinicalmastitiscausedbyawiderangeoforganismsincludingthefollowing

pathogenshavebeenshowntorespondtotreatmentwithcefoperazone.

-Streptococcusdysgalactiae

-Streptococcusuberis

-Streptococcusagalactiae

-Staphylococcusaureus(includingpenicillinaseproducingstrains)

-Escherichiacoli

-Trueperellapyogenes

-Pseudomonasaeruginosa

-Micrococcusspp.

-Klebsiellaspp.

4.3Contraindications

Donotuseincaseofhypersensitivitytocephalosporinsortoanyoftheexcipentsor

incaseofseveredisturbanceofkidneyfunction.

ISSUED:December2012

AN:01574/2011

Page2of4

4.4Specialwarningsforeachtargetspecies

Itisnotenvisagedforthisproducttobeadministratedtospeciesotherthanlactating

cattle.

4.5Specialprecautionsforuse

Specialprecautionsforuseinanimals

Useoftheproductshouldbebasedonsusceptibilitytestingandshouldtakeinto

accountofficialandlocalantimicrobialpolicies.

Specialprecautionstobetakenbythepersonadministeringtheveterinary

medicinalproducttoanimals

Penicillinsandcephalosporinsmaycausehypersensitivity(allergy)following

injection,inhalation,ingestionorskincontact.Hypersensitivitytopenicillinsmaylead

tocross-reactionstocephalosporinsandvice-versa.Allergicreactiontothese

substancesmayoccasionallybeserious.

Donothandlethisproductifyouknowyouaresensitised,orifyouhavebeen

advisednottoworkwithsuchpreparations.

Handlethisproductwithgreatcaretoavoidexposure,takingallrecommended

precautions.

Ifyoudevelopsymptoms,suchasaskinrash,youshouldseekmedicaladviceand

showthedoctorthiswarningorthepackageleaflet.Swellingoftheface,lipsoreyes

ordifficultywithbreathingaremoreserioussymptomsandmayrequireurgent

medicalattention.Washhandsafteruse.

4.6Adversereactions(frequencyandseriousness)

None.

4.7Useduringpregnancy,lactationorlay

Bydefinitiontheproducthasbeendevelopedforuseinlactatingcowsandhasbeen

showntobesafeinthatregard.

Inreproductivestudiesnoadversefindingshavebeenseenwhichmightmakethe

productunsafeinpregnantanimals.

4.8Interactionwithothermedicinalproductsandotherformsofinteraction

Cefoperazoneisnotcompatiblewithaminoglycosideantibioticsuchasstreptomycin,

neomycinandgentamycin.Thesimultaneousadministrationofpossiblynephrotoxic

drugsmayprolongtheeliminationofcefoperazone.

Thereisararepossibilityofcrossreactionwithotherbeta-lactamantibiotics.

4.9Amountstobeadministeredandadministrationroute

Forintramammaryuse.Singleadministration.Thecontentsofone10mlsyringe

shouldbeinjectedintotheinfectedquarterimmediatelyaftermilking.Beforeinjection

theteatshouldbethoroughlycleanedanddisinfected.

ISSUED:December2012

AN:01574/2011

Page3of4

4.10Overdose(symptoms,emergencyprocedures,antidotes),ifnecessary

Overdosingisunlikelytobeaproblemasthecontentsofafullsyringehavebeen

administered.

4.11Withdrawalperiod(s)

Meatandoffal: 2days

Milk: 72hours

5. PHARMACOLOGICALPROPERTIES

Pharmacotherapeuticgroup:Antibacterialforintramammaryuse,cephalosporinsand

relatedsubstances

ATCvetcode:QJ51DD12

5.1Pharmacodynamicproperties

Cefoperazoneisathirdgeneration,semi-syntheticcephalosporinantibioticwitha

broadspectrumofbactericidalactivitycoveringbothGram-positiveandGram-

negativeorganisms.Itactsbyinhibitionofbacterialcellwallsynthesis.Asathird

generationcephalosporin,cefoperazoneshowsgreaterabilitytowithstand

degradationbybeta-lactamaseenzymesthandomembersofthefirstandsecond

generationswhoseactivityinthepresenceofbeta-lactamasesisthereforeless

reliable.

5.2Pharmacokineticparticulars

Systemicdrugabsorptionofcefaperazonehasbeenfoundtobenegligibleinhealthy

animals,whereasittendstobehigherininfectedanimals,probablyduetothe

damagetoepithelialcelljunctionscausedbysubclinicalinfections.

Thedetectedurineconcentrationsindicatethatcefoperazoneisabsorbedfromthe

udderandisatleastpartlyexcretedbythekidneys.Intissueresiduestudies,no

residuesweredetectedinsamplesofmuscle,liver,kidney,fat,heartor

supramammarylymphnode.

Thehighestconcentrationsofcefoperazoneinmilkaredetectedatthefirstmilking

(12hours)afteradministration.Fromfivedaysafteradministration,cefoperazoneis

notdetectableinthemilk.Milkyielddoesnotinfluencethepercentageof

cefoperazoneexcretedinthemilk.

6. PHARMACEUTICALPARTICULARS

6.1Listofexcipients

all-rac- α-Tocopherol(E307)

Glycerolmonostearate

Sorbitanstearate

Arachisoil,Refined

ISSUED:December2012

AN:01574/2011

Page4of4

6.2Incompatibilities

Cefoperazoneisnotphysico-chemicallycompatiblewithdrugsoftheaminoglycoside

group.

6.3Shelflife

Shelf-lifeoftheveterinarymedicinalproductaspackagedforsale:18months.

6.4.Specialprecautionsforstorage

Donotstoreabove25

C.

Forsingleuseonly.

6.5Natureandcompositionofimmediatepackaging

10mlwhiteopaquelowdensitypolyethylenesyringefittedwithaprotectivecapofred

lowdensitypolyethylene.Cartonscontainfoursyringes.

6.6Specialprecautionsforthedisposalofunusedveterinarymedicinalproduct

orwastematerialsderivedfromtheuseofsuchproducts

Anyunusedveterinarymedicinalproductorwastematerialsderivedfromsuch

veterinarymedicinalproductsshouldbedisposedofinaccordancewithlocal

requirements.

7. MARKETINGAUTHORISATIONHOLDER

PfizerLimited

RamsgateRoad

Sandwich

KentCT139NJ

UK

8. MARKETINGAUTHORISATIONNUMBER

Vm00057/4438

9. DATEOFFIRSTAUTHORISATION

14December2012

10.DATEOFREVISIONOFTHETEXT

December2012

Approved: 14/12/2012

7-12-2018

Magnesium citrate malate as a source of magnesium added for nutritional purposes to food supplements

Magnesium citrate malate as a source of magnesium added for nutritional purposes to food supplements

Published on: Thu, 06 Dec 2018 The present scientific opinion deals with the assessment of the bioavailability of magnesium, from the proposed nutrient source, magnesium citrate malate (MgCM), when added for nutritional purposes to food supplements. MgCM is a mixed salt consisting of magnesium cations and citrate and malate anions, and with a magnesium content of 12–15%. MgCM is proposed to be used in food supplements that are intended to provide up to 300–540 mg/day magnesium. The data provided demonst...

Europe - EFSA - European Food Safety Authority Publications

3-8-2018

Scientific guideline:  Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance, adopted

Scientific guideline: Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance, adopted

Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance

Europe - EFSA - European Food Safety Authority EFSA Journal

31-7-2018

Public Notification: Black Rhino 25000 contains hidden drug ingredient

Public Notification: Black Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Black Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Krazzy Rhino 25000 contains hidden drug ingredient

Public Notification: Krazzy Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Krazzy Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Gold Rhino 25000 contains hidden drug ingredient

Public Notification: Gold Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Gold Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Platinum Rhino 25000 contains hidden drug ingredient

Public Notification: Platinum Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Platinum Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

10-7-2018

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

PrEP wordt binnen een onderzoekssetting voor een periode van vijf jaar verstrekt aan de hoogrisicogroep van mannen die seks hebben met mannen (MSM). Dat heeft minister Bruno Bruins (Medische Zorg) vandaag bekend gemaakt. Op basis van schattingen van het RIVM zullen ongeveer 6500 mannen hiervan gebruik gaan maken en kunnen hiermee  250 hiv-infecties per jaar worden voorkomen. Voor gebruikers gaat een eigen bijdrage gelden van maximaal 25%, dat komt overeen met ongeveer 12 euro per maand. Ook wordt hen gev...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

4-5-2018

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals, LLC of Springville, Utah is recalling Green Suma, Red Suma, Green Hulu 2, and Red Hulu 2 kratom dietary supplements sold directly to consumers via the company website from January 1st, 2018 to April l 12th, 2018 in pouches of 250g, because it has the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

15-1-2014

Revocation of wholesale distribution and manufacturing authorisations granted to Singad Pharma ApS

Revocation of wholesale distribution and manufacturing authorisations granted to Singad Pharma ApS

On 20 December 2013 and on 10 January 2014, the Danish Health and Medicines Authority decided to revoke the section 39 authorisations for wholesale distribution and manufacturing of medicinal products with the authorisation IDs 25081 and 25082 granted to Singad Pharma ApS (company number 255894).

Danish Medicines Agency

30-10-2018

EU/3/14/1250 (Akcea Therapeutics UK Ltd)

EU/3/14/1250 (Akcea Therapeutics UK Ltd)

EU/3/14/1250 (Active substance: Phosphorothioate oligonucleotide targeted to transthyretin) - Transfer of orphan designation - Commission Decision (2018)7282 of Tue, 30 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/098/13/T/01

Europe -DG Health and Food Safety

6-6-2018

Stocrin (Merck Sharp and Dohme B.V.)

Stocrin (Merck Sharp and Dohme B.V.)

Stocrin (Active substance: efavirenz) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3689 of Wed, 06 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/250/T/113

Europe -DG Health and Food Safety